Stanislav Glezer
Director/Board Member chez Diabetes Foundation of New Jersey
Fortune : 207 678 $ au 30/04/2024
Postes actifs de Stanislav Glezer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Diabetes Foundation of New Jersey | Director/Board Member | 24/07/2019 | - |
Historique de carrière de Stanislav Glezer
Anciens postes connus de Stanislav Glezer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOGEN, INC. | Chief Tech/Sci/R&D Officer | 21/06/2021 | 03/05/2024 |
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 01/09/2018 | 01/06/2021 |
| ADOCIA | Chief Tech/Sci/R&D Officer | 26/07/2017 | 01/05/2018 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2016 | 01/03/2017 |
| Sanofi SA | Corporate Officer/Principal | - | - |
Formation de Stanislav Glezer
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| France | 3 |
| Russie | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Bourse
- Insiders
- Stanislav Glezer
- Expérience
